Skip to content

SOPHiA DDM Dx RNAtarget Oncology Solution

by SOPHiA GENETICS SA EUDAMED

Active European Union

Ref BS0119ILLCSRY07-32

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-BS0119ILLCSRY07-32F3 Basic UDI-DIDate24 Jun 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED

Device Name
SOPHiA DDM Dx RNAtarget Oncology Solution
Model / Reference
BS0119ILLCSRY07-32
Primary DI / UDI-DI
D-BS0119ILLCSRY07-32F3
Basic UDI-DI
B-BS0119ILLCSRY07-32F3
EMDN Code
W01060299 Tests for acquired genetic or chromosomal alterations - other
Device Class
Class IVD General
Market of Registration
France

Manufacturer details

EUDAMED SRN
CH-MF-000025221
Authorised representative
SOPHiA GENETICS SAS FR-AR-000022214

Other devices from SOPHiA GENETICS SA

See all devices from SOPHiA GENETICS SA →

Properties

  • Microbial Substances
  • Reagent
  • Professional Testing

Other properties (7)

  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No